Evaluation of Hepatic Enzyme Activity, Drug Metabolism, and Physiological Alterations in Patients Receiving Long-Term Pharmacotherapy: A Systematic Review
Journal of Diabetes, Metabolism and Endocrinology · 2026
DOI: 10.61336/jdme.0704.12 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Diabetes, Metabolism and Endocrinology, 2026. Verfasst von Subham Das und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Prolonged medication exposure can influence circulating liver-associated enzymes, hepatic biotransformation, transport and physiological functions. These consequences are not equivalent: aminotransferase elevations indicate injury rather than directly measuring CYP activity or clearance.
Objective
To evaluate hepatic biochemical, pharmacokinetic and physiological outcomes during long-term pharmacotherapy, with attention to drug-class and host-related variability.
Methods
The information-source window was specified from database inception to 30 June 2026. A PRISMA 2020-informed review framework defined medication exposure, hepatic injury, metabolic activity and physiological outcomes. Published clinical cohorts, drug-safety monographs and systematic reviews were examined descriptively; no new pooled meta-analysis was performed.
Results
In a prospective DILIN cohort, 899 patients had probable or more certain Drug-Induced Liver Injury (DILI); 10% died or underwent transplantation and 17% experienced chronic injury. A separate published synthesis of 160 antituberculosis studies (116,147 participants) reported 11.50% liver injury (95% CI 10.10–12.97%; I² 98.2%). Liver Tox reports asymptomatic ALT elevations in approximately 5–10% of patients using valproate. Inflammation-mediated alterations in CYP activity have been documented in clinical and mechanistic studies.
Conclusion
Assessment of medication-related hepatic effects should distinguish hepatocellular injury from metabolic clearance and systemic physiological function, and should integrate medication exposure, clinical context and appropriate laboratory investigation.
Zitieren
APA
Das, S., Singh, N., & Yadav, A. (2026). Evaluation of Hepatic Enzyme Activity, Drug Metabolism, and Physiological Alterations in Patients Receiving Long-Term Pharmacotherapy: A Systematic Review. Journal of Diabetes, Metabolism and Endocrinology. https://doi.org/10.61336/jdme.0704.12
Vancouver
Das S, Singh N, Yadav A. Evaluation of Hepatic Enzyme Activity, Drug Metabolism, and Physiological Alterations in Patients Receiving Long-Term Pharmacotherapy: A Systematic Review. Journal of Diabetes, Metabolism and Endocrinology. 2026. doi:10.61336/jdme.0704.12
BibTeX
@article{Das2026,
author = {Das, Subham and Singh, Neetu and Yadav, Amit},
title = {Evaluation of Hepatic Enzyme Activity, Drug Metabolism, and Physiological Alterations in Patients Receiving Long-Term Pharmacotherapy: A Systematic Review},
journal = {Journal of Diabetes, Metabolism and Endocrinology},
year = {2026},
doi = {10.61336/jdme.0704.12}
}
EUVIMED